grade
pharmaceutical primary standard
API family
epinephrine
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
SMILES string
O[C@H]([C@@H](O)C(O)=O)C(O)=O.CNC[C@H](O)c1ccc(O)c(O)c1
InChI
1S/C9H13NO3.C4H6O6/c1-10-5-9(13)6-2-3-7(11)8(12)4-6;5-1(3(7)8)2(6)4(9)10/h2-4,9-13H,5H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t9-;1-,2-/m01/s1
InChI key
YLXIPWWIOISBDD-NDAAPVSOSA-N
Gene Information
human ... ADRA1A(148), ADRA1B(147), ADRA1D(146), ADRA2A(150), ADRA2B(151), ADRA2C(152), ADRB1(153), ADRB2(154), ADRB3(155)
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
Application
Epinephrine bitartrate USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:
- Epinephrine Bitartrate Ophthalmic Solution
- Racepinephrine
- Lidocaine Hydrochloride and Epinephrine Injection
- Bupivacaine Hydrochloride and Epinephrine Injection
- Racepinephrine Hydrochloride
- Epinephrine Injection
Biochem/physiol Actions
Adrenergic receptor agonist.
Analysis Note
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
Other Notes
Sales restrictions may apply.
Still not finding the right product?
Explore all of our products under Epinephrine bitartrate
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 1 Oral
저장 등급
6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
flash_point_f
Not applicable
flash_point_c
Not applicable
Epinephrine Bitartrate
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 44(5) (2021)
Epinephrine Bitartrate Ophthalmic Solution
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 1651-1651 (2013)
Yangjie Wei et al.
AAPS PharmSciTech, 16(2), 455-465 (2014-11-02)
Several attempts have been made to mask the bitter taste of oral formulations, but none have been made for injectable formulations. This study aims to mask the bitter taste of dental lidocaine HCl (LID) injection using hydroxypropyl-β-cyclodextrin (HP-β-CD) and sodium